Shuanglin Qin

573 total citations
34 papers, 328 citations indexed

About

Shuanglin Qin is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Shuanglin Qin has authored 34 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 13 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Shuanglin Qin's work include Pharmacological Effects of Natural Compounds (6 papers), Synthesis and Catalytic Reactions (5 papers) and Catalytic C–H Functionalization Methods (4 papers). Shuanglin Qin is often cited by papers focused on Pharmacological Effects of Natural Compounds (6 papers), Synthesis and Catalytic Reactions (5 papers) and Catalytic C–H Functionalization Methods (4 papers). Shuanglin Qin collaborates with scholars based in China, United States and United Kingdom. Shuanglin Qin's co-authors include Mengwei Xu, Zhaofang Bai, Rui Peng, Xiaohe Xiao, Guang Yang, Shende Jiang, Si Yan, Xin Chen, Ziwei Du and Guang Xu and has published in prestigious journals such as The Journal of Organic Chemistry, Molecules and Organic Letters.

In The Last Decade

Shuanglin Qin

32 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuanglin Qin China 13 152 114 57 41 30 34 328
Qin Qiu China 9 112 0.7× 70 0.6× 34 0.6× 46 1.1× 43 1.4× 27 366
Hongfei Chen China 14 210 1.4× 135 1.2× 57 1.0× 22 0.5× 8 0.3× 37 429
Bharat Goel India 11 162 1.1× 76 0.7× 24 0.4× 36 0.9× 11 0.4× 38 344
Oksana V. Salomatina Russia 12 225 1.5× 107 0.9× 31 0.5× 116 2.8× 24 0.8× 43 400
Bishoy El‐Aarag Egypt 12 133 0.9× 75 0.7× 35 0.6× 50 1.2× 13 0.4× 26 389
Fabien Lecomte United Kingdom 8 169 1.1× 236 2.1× 34 0.6× 39 1.0× 25 0.8× 9 432
Zhongren Xu China 10 171 1.1× 152 1.3× 69 1.2× 33 0.8× 26 0.9× 17 494
Zhengguang Zhu China 14 228 1.5× 151 1.3× 55 1.0× 60 1.5× 15 0.5× 29 544
Pravat Kumar Parida India 11 125 0.8× 64 0.6× 19 0.3× 14 0.3× 35 1.2× 17 329
Dae Won Park South Korea 10 141 0.9× 67 0.6× 46 0.8× 44 1.1× 20 0.7× 26 407

Countries citing papers authored by Shuanglin Qin

Since Specialization
Citations

This map shows the geographic impact of Shuanglin Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuanglin Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuanglin Qin more than expected).

Fields of papers citing papers by Shuanglin Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuanglin Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuanglin Qin. The network helps show where Shuanglin Qin may publish in the future.

Co-authorship network of co-authors of Shuanglin Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Shuanglin Qin. A scholar is included among the top collaborators of Shuanglin Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuanglin Qin. Shuanglin Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yan, et al.. (2025). The Double-Edge Sword of Natural Phenanthrenes in the Landscape of Tumorigenesis. Molecules. 30(6). 1204–1204. 2 indexed citations
2.
Yan, Si, et al.. (2025). PROTACs coupled with oligonucleotides to tackle the undruggable. Bioanalysis. 17(4). 261–276. 2 indexed citations
4.
Yang, Huijie, Hongbo Wang, Shuanglin Qin, et al.. (2024). Tryptanthrin suppresses multiple inflammasome activation to regulate NASH progression by targeting ASC protein. Phytomedicine. 131. 155758–155758. 6 indexed citations
5.
Yan, Si, Wei Luo, Mengwei Xu, et al.. (2024). PROTAC technology: From drug development to probe technology for target deconvolution. European Journal of Medicinal Chemistry. 276. 116725–116725. 37 indexed citations
7.
Zheng, Song, Guang Xu, Hongbo Wang, et al.. (2024). LicochalconeB inhibits cGAS-STING signaling pathway and prevents autoimmunity diseases. International Immunopharmacology. 128. 111550–111550. 15 indexed citations
8.
Xu, Mengwei, Zhaofang Bai, Baocheng Xie, et al.. (2024). Marine-Derived Bisindoles for Potent Selective Cancer Drug Discovery and Development. Molecules. 29(5). 933–933. 13 indexed citations
10.
Li, Hui, Wei Shi, Ziying Wei, et al.. (2023). Network pharmacology-based strategy for predicting therapy targets of Ecliptae Herba on breast cancer. Medicine. 102(41). e35384–e35384. 14 indexed citations
11.
Wang, Yan, Shuanglin Qin, Huanying Zhao, et al.. (2023). Helenine blocks NLRP3 activation by disrupting the NEK7-NLRP3 interaction and ameliorates inflammatory diseases. Phytomedicine. 122. 155159–155159. 14 indexed citations
12.
Qin, Shuanglin, Yurong Li, Ping Zhang, et al.. (2023). Flavonoids derived from licorice suppress LPS-induced acute lung injury in mice by inhibiting the cGAS-STING signaling pathway. Food and Chemical Toxicology. 175. 113732–113732. 26 indexed citations
13.
Xu, Mengwei, Baocheng Xie, Qing Min, et al.. (2023). Insights on Antitumor Activity and Mechanism of Natural Benzophenanthridine Alkaloids. Molecules. 28(18). 6588–6588. 14 indexed citations
14.
Li, Hui, Xiaoyan Zhan, Wei Luo, et al.. (2023). Glabridin improves autoimmune disease in Trex1-deficient mice by reducing type I interferon production. Molecular Medicine. 29(1). 167–167. 9 indexed citations
15.
Tang, Jinfa, et al.. (2022). A review of herb-induced liver injury in mainland china. Frontiers in Pharmacology. 13. 813073–813073. 12 indexed citations
16.
Wang, Xiaoji, Shuanglin Qin, Yue Sun, et al.. (2020). Rh-Catalyzed diastereo- and linear-selective α-allylation of chiral cycloenamines. Organic Chemistry Frontiers. 7(22). 3715–3719. 1 indexed citations
17.
Jiang, Shende, Guang Yang, Shuanglin Qin, et al.. (2019). An Efficient Method for Constructing Cyclic β-Amino Acids Bearing Quaternary Stereocenters. Synlett. 30(5). 593–599. 9 indexed citations
18.
Qin, Shuanglin, et al.. (2019). Diastereoselective Rh-catalyzed decarboxylative allylation to form quaternary stereocenters using sulfinimine as the directing group. Organic Chemistry Frontiers. 6(6). 732–735. 10 indexed citations
19.
Gao, Xian, Lisong Zhang, Shuanglin Qin, et al.. (2018). A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway. European Journal of Medicinal Chemistry. 156. 21–42. 16 indexed citations
20.
Huang, Fei, et al.. (2014). Synthesis of the Key Intermediate of (+)-(6S,2'R)-Cryptocaryalactone. Advanced materials research. 1033-1034. 566–568. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026